Tue, December 8, 2009
Mon, December 7, 2009
Sun, December 6, 2009
Sat, December 5, 2009
Fri, December 4, 2009
Thu, December 3, 2009
Wed, December 2, 2009
[ Wed, Dec 02nd 2009 ] - Market Wire
GIE names new directors
Tue, December 1, 2009
Mon, November 30, 2009
Sun, November 29, 2009
Sat, November 28, 2009
Fri, November 27, 2009
Thu, November 26, 2009
Wed, November 25, 2009
Tue, November 24, 2009
Mon, November 23, 2009
Fri, November 20, 2009
[ Fri, Nov 20th 2009 ] - Market Wire
Indico Closes Financing

Tekmira Pharmaceuticals to Webcast Presentation at the Piper Jaffray Health Care Conference


//business-finance.news-articles.net/content/200 .. at-the-piper-jaffray-health-care-conference.html
Published in Business and Finance on Monday, November 30th 2009 at 21:30 GMT by Market Wire   Print publication without navigation


VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 30, 2009) - Tekmira Pharmaceuticals Corporation (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics and proprietary delivery technology, announced today that the Company's President and Chief Executive Officer, Dr. Mark Murray, will present at the Piper Jaffray 21st Annual Health Care Conference on Tuesday December 1, 2009 at 9:30 am ET at the New York Palace Hotel in New York City. A webcast of the presentation will be available and can be accessed on the Company's website, [ www.tekmirapharm.com ].

About Tekmira

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Further information about Tekmira can be found at [ www.tekmirapharm.com ]. Tekmira is based in Vancouver, B.C.




Publication Contributing Sources